Global Health Investment Fund Our namesake $108 million social impact fund (GHIF) invested in twelve companies developing clinical diagnostics, devices, vaccines, and therapeutics targeting infectious diseases that disproportionately burden low- and middle-income countries, such as HIV/AIDS, malaria, tube...
Global Health Investment Advisors (dba Global Health Funds) served as the Investment Manager for the pioneering Global Health Investment Fund (“GHIF”) from 2015 through the fund’s conclusion in 2023. GHIF made 12 investments, producing top quartile financial returns and introducing over a dozen...
简介:Global Health Investment Fund(GHIF)是一个1.08亿美元的社会影响投资基金,旨在提供资金,推动药物、疫苗、诊断和其他干预措施的开发,以应对给低收入和中等收入国家带来极大负担的疾病。 投资项目8 投资事件11 机构明细0 上榜榜单0 投资项目8 战绩类型所属行业导出 ...
Global Health Investment Corporation, and CPP Investments also participated in the round. The company is a developer of biophysical markers intended to revolutionize diagnostics using cell mechanics and machine learning. Suki: The company raised $70 million of Series D venture funding in a deal led ...
Maternal health in the U.S. presents a critical investment opportunity as the country grapples with one of the highest maternal mortality rates among developed nations. Startups focused on maternal health, from advanced monitoring technologies to telehealth platforms, are paving the way for safer pr...
Our investment process is supported byGHIN(Global Health Impact Network), an expert network of 2,000+ clinicians across 40 different medical fields. Our Values Expertise Throughout the startup journey, GHIF supports founders as a trusted advisor. We provide validation for product ideas, makevaluab...
The article presents information on the launch of a global health Research & Development (R&D) investment fund by finance company J.P. Morgan Chase & Co., the Bill & Melinda Gates Foundation, a nonprofit organization, and several other corporates in the U.S. It informs that the fund has ...
innovative therapies in areas of high unmet need. Through its partnership with OrbiMed, Johnson & Johnson and Takeda, RMGP provides an opportunity to invest in the cutting-edge portfolio of the FutuRx incubator. The RMGP Biopharma Investment Fund is managed by RM Global Healthcare Fund ...
Global health sciences venture fund 2016-01-01加拿大外资 简介:Global health sciences venture fund是一个投资公司。 投资动态4 EyeYon 参与轮次 C轮 投资金额 2500万美元 投资时间 2021-03-20 革新角膜护理,以色列新锐完成2500万美元融资 CalciMedica 参与轮次 D轮 投资金额 2100万美元 投资时间 2021-03-16 ...
普通合伙人发起设立的GlobalHealthScienceFundII,L.P.(全球健康科学基金,以下简 称“基金”)。 本次投资共计3,000万美元,约占本公司最近一期经审计归属于本公司股东净资产 (人民币650,598.74万元)的3.01%,根据相关规定,本次对外投资无需提交公司股东